CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,103,173 | -50.1% | 94,369 | -42.6% | 0.00% | -66.7% |
| Q2 2023 | $2,208,769 | -29.1% | 164,343 | -1.8% | 0.00% | -25.0% |
| Q4 2022 | $3,114,291 | +211.4% | 167,435 | +17.4% | 0.00% | +300.0% |
| Q2 2022 | $1,000,000 | -18.0% | 142,629 | -3.0% | 0.00% | 0.0% |
| Q1 2022 | $1,219,000 | +15.8% | 147,031 | -5.5% | 0.00% | 0.0% |
| Q4 2021 | $1,053,000 | +45.8% | 155,566 | +14.3% | 0.00% | 0.0% |
| Q3 2021 | $722,000 | -48.5% | 136,158 | -44.2% | 0.00% | -50.0% |
| Q2 2021 | $1,403,000 | +20.0% | 244,062 | -3.7% | 0.00% | +100.0% |
| Q1 2021 | $1,169,000 | +50.1% | 253,563 | +8.7% | 0.00% | 0.0% |
| Q4 2020 | $779,000 | +7.7% | 233,210 | -4.2% | 0.00% | 0.0% |
| Q3 2020 | $723,000 | – | 243,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |